The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-300

Today could be quite an interesting Friday given it could potentially be the last opportunity to enter before the Phase 1 results are presented next week.

Then there are multiple catalysts that may follow in the short term:

- Receive ODD
- Potential partnerships
- FightMND grant
- Phase 2 trial commences

MT said that FDA would have likely approved ODD based on survival data.

What we know about the trial is that all 12 patients are still with us. The fact that they haven't lost the ability to swallow at this stage and are continuing treatment suggests that it is providing benefit.

MT is doing all the right things to position the company for a great future.